You have 9 free searches left this month | for more free features.

glioma of WHO Grade III or IV

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)

Not yet recruiting
  • High Grade Glioma
  • Glioblastoma
  • Standard Surgical Treatment
  • Intraoperative Electrocorticography
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022

Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)

Not yet recruiting
  • Grade III or Grade IV Glioma
  • PET imaging with 18F fluciclovine
  • (no location specified)
Jul 27, 2022

Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

Active, not recruiting
  • Glioma of Brain
  • Bern, Switzerland
  • +2 more
Apr 7, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Supramaximal Resection Versus Maximal Resection for High-Grade

Recruiting
  • Glioblastoma
  • +11 more
  • Supramaximal resection
  • Maximal safe resection
  • San Francisco, California
  • +7 more
Nov 1, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)

    Completed
    • High Grade Glioma
    • endurance training
    • +2 more
    • Basel, Switzerland
    • +1 more
    May 17, 2022

    Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Stereotactic Radiosurgery
    • Lake Success, New York
      Northwell Health Brain Tumor Center
    Feb 3, 2022

    Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

    Recruiting
    • Glioblastoma
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • Quality-of-Life
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

    Recruiting
    • Recurrent World Health Organization (WHO) Grade II Glioma
    • +3 more
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Dec 21, 2022

    Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

    Recruiting
    • Grade II Glioma
    • +7 more
    • Microdevice
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 22, 2021

    Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

    Not yet recruiting
    • Malignant Glioma
    • Glioblastoma
    • hEGFRvIII-CD3 (BRiTE)
    • Activated Cell Therapy
    • Durham, North Carolina
      Duke University Medical Center
    Jun 24, 2022

    Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)

    Recruiting
    • Glioblastoma Multiforme
    • Perillyl alcohol
    • Los Angeles, California
    • +1 more
    Sep 23, 2022

    Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

    Recruiting
    • Astrocytoma, Grade IV
    • +7 more
      • Valencia, Spain
        Biomedical Data Science Lab. Universitat Politècnica de València
      May 11, 2022

      Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

      Recruiting
      • Anaplastic Astrocytoma, IDH-Wildtype
      • +8 more
      • Quality-of-Life Assessment
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 8, 2022

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Withdrawn
      • Recurrent Anaplastic Astrocytoma
      • +7 more
      • Neural Stem Cells-expressing CRAd-S-pk7
      • Resection
      • (no location specified)
      Nov 22, 2022

      GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

      Completed
      • GBM
      • +3 more
      • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
      • Durham, North Carolina
        Duke University Medical Center
      Jun 28, 2022

      Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

      Active, not recruiting
      • Grade III Astrocytoma
      • +3 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jun 9, 2022

      Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)

      Recruiting
      • Glioblastoma
      • +3 more
      • Phoenix, Arizona
        St. Joseph's Hospital and Medical Center
      Mar 10, 2022

      Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

      Recruiting
      • Glioblastoma
      • +5 more
      • Ipilimumab
      • +4 more
      • Birmingham, Alabama
      • +19 more
      Aug 16, 2022

      Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)

      Recruiting
      • Glioma
      • Glioblastoma
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      Jan 31, 2022

      Malignant Glioma Trial in United States (PVSRIPO)

      Active, not recruiting
      • Malignant Glioma
      • PVSRIPO
      • San Francisco, California
      • +5 more
      Jun 28, 2022

      Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

      Suspended
      • Glioblastoma
      • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
      • +4 more
      • Durham, North Carolina
        Duke University Medical Center
      Aug 16, 2022

      Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

      Recruiting
      • Intracranial Neoplasm
      • +4 more
      • F-18 Fluoroethyltyrosine (FET)
      • Positron Emission Tomography (PET)
      • San Francisco, California
        University of California, San Francisco
      Nov 7, 2022